Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis
2008

The Role of Neuropeptide Y in Colitis

publication Evidence: moderate

Author Information

Author(s): Bindu Chandrasekharan, Vanitha Bala, Vasantha L. Kolachala, Matam Vijay-Kumar, Dean Jones, Andrew T. Gewirtz, Shanthi V. Sitaraman, Shanthi Srinivasan

Primary Institution: Emory University

Hypothesis

An increase in neuropeptide Y (NPY) leads to an increase in nNOS neurons, resulting in increased oxidative stress, thereby aggravating colonic inflammation.

Conclusion

NPY mediated increase in nNOS is a determinant of oxidative stress and subsequent inflammation.

Supporting Evidence

  • DSS/S.T. induced an increase in enteric neuronal NPY and nNOS expression in WT mice.
  • WT mice were more susceptible to inflammation compared to NPY−/− as indicated by higher clinical & histological scores.
  • The lower histological scores in NPY−/− mice supported the finding that loss of NPY-induced nNOS attenuated inflammation.
  • NPY−/− mice exhibited less inflammation with an overall clinical score of 4±0.7 compared to a score of 9±0.5 in DSS-WT mice.

Takeaway

This study shows that a substance called neuropeptide Y can make inflammation in the gut worse, and that removing it helps reduce this inflammation.

Methodology

Colitis was induced in mice using dextran sodium sulfate and Salmonella, and inflammation was assessed through clinical scores, histological scores, and myeloperoxidase activity.

Participant Demographics

Mice used in the study included wild type and various knockout strains.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0003304

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication